Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ubiquitin-Protein Ligases | 31 | 2024 | 1887 | 3.610 |
Why?
|
Thalidomide | 12 | 2024 | 884 | 1.920 |
Why?
|
Ubiquitination | 18 | 2024 | 1006 | 1.700 |
Why?
|
Peptide Hydrolases | 7 | 2018 | 622 | 1.430 |
Why?
|
Cryoelectron Microscopy | 7 | 2024 | 642 | 1.240 |
Why?
|
Small Molecule Libraries | 8 | 2021 | 724 | 1.080 |
Why?
|
Ikaros Transcription Factor | 7 | 2022 | 231 | 1.040 |
Why?
|
Transcription Factors | 17 | 2024 | 12094 | 1.020 |
Why?
|
Protein Phosphatase 2 | 2 | 2024 | 235 | 0.950 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2023 | 197 | 0.800 |
Why?
|
Proteasome Endopeptidase Complex | 4 | 2024 | 1312 | 0.760 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2023 | 1134 | 0.730 |
Why?
|
Substrate Specificity | 9 | 2024 | 1792 | 0.730 |
Why?
|
Adaptor Proteins, Signal Transducing | 13 | 2022 | 2895 | 0.720 |
Why?
|
Caspases | 1 | 2023 | 876 | 0.680 |
Why?
|
Protein Kinase Inhibitors | 14 | 2023 | 5629 | 0.630 |
Why?
|
Structure-Activity Relationship | 9 | 2024 | 3069 | 0.620 |
Why?
|
Drug Design | 4 | 2021 | 1049 | 0.620 |
Why?
|
Cell Cycle Proteins | 5 | 2024 | 3442 | 0.610 |
Why?
|
Proteomics | 9 | 2024 | 3816 | 0.610 |
Why?
|
Proteins | 5 | 2024 | 6026 | 0.610 |
Why?
|
Crystallography, X-Ray | 11 | 2024 | 1974 | 0.600 |
Why?
|
Duane Retraction Syndrome | 1 | 2018 | 59 | 0.590 |
Why?
|
Polymerization | 3 | 2024 | 157 | 0.590 |
Why?
|
Ubiquitin | 5 | 2024 | 837 | 0.590 |
Why?
|
Chromatin | 5 | 2024 | 2938 | 0.580 |
Why?
|
Drug Discovery | 4 | 2024 | 1044 | 0.560 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 977 | 0.560 |
Why?
|
Histone Deacetylases | 1 | 2021 | 718 | 0.550 |
Why?
|
Acetamides | 1 | 2018 | 255 | 0.540 |
Why?
|
Proteome | 3 | 2022 | 1855 | 0.490 |
Why?
|
Polymers | 1 | 2022 | 1616 | 0.480 |
Why?
|
Immunologic Factors | 2 | 2022 | 1585 | 0.470 |
Why?
|
Protein Binding | 13 | 2024 | 9311 | 0.470 |
Why?
|
HEK293 Cells | 7 | 2024 | 4257 | 0.450 |
Why?
|
Tumor Suppressor Proteins | 4 | 2024 | 2800 | 0.450 |
Why?
|
Thiophenes | 1 | 2018 | 569 | 0.450 |
Why?
|
Protein Kinases | 1 | 2020 | 1610 | 0.440 |
Why?
|
Sulfonamides | 2 | 2020 | 1973 | 0.430 |
Why?
|
Models, Molecular | 10 | 2021 | 5410 | 0.430 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2019 | 2872 | 0.430 |
Why?
|
Molecular Structure | 6 | 2024 | 1866 | 0.420 |
Why?
|
Dengue Virus | 2 | 2024 | 200 | 0.410 |
Why?
|
Multiprotein Complexes | 5 | 2024 | 1120 | 0.410 |
Why?
|
Nuclear Proteins | 5 | 2024 | 5786 | 0.400 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 2 | 2024 | 300 | 0.390 |
Why?
|
Peptide Termination Factors | 2 | 2022 | 56 | 0.380 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 3 | 2024 | 305 | 0.380 |
Why?
|
Indoles | 1 | 2019 | 1828 | 0.380 |
Why?
|
Cell Line | 9 | 2024 | 15591 | 0.370 |
Why?
|
Binding Sites | 9 | 2024 | 6036 | 0.370 |
Why?
|
Apoptosis | 7 | 2024 | 9468 | 0.360 |
Why?
|
Antibodies, Viral | 4 | 2023 | 3142 | 0.360 |
Why?
|
DNA-Binding Proteins | 7 | 2021 | 9574 | 0.350 |
Why?
|
Biocatalysis | 3 | 2023 | 170 | 0.350 |
Why?
|
Protein Multimerization | 3 | 2024 | 979 | 0.350 |
Why?
|
Cell Line, Tumor | 25 | 2024 | 16886 | 0.350 |
Why?
|
Ligands | 8 | 2023 | 3258 | 0.350 |
Why?
|
Lymphoma, T-Cell | 2 | 2023 | 304 | 0.350 |
Why?
|
Drug Resistance, Neoplasm | 8 | 2023 | 5249 | 0.340 |
Why?
|
Cyclins | 2 | 2023 | 593 | 0.340 |
Why?
|
Antineoplastic Agents | 13 | 2024 | 13591 | 0.330 |
Why?
|
Casein Kinase Ialpha | 2 | 2021 | 26 | 0.330 |
Why?
|
Methyltransferases | 2 | 2023 | 374 | 0.330 |
Why?
|
Catalytic Domain | 5 | 2024 | 705 | 0.320 |
Why?
|
Zinc Fingers | 2 | 2024 | 568 | 0.320 |
Why?
|
Fluorescence Resonance Energy Transfer | 2 | 2023 | 418 | 0.320 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2021 | 3071 | 0.290 |
Why?
|
Humans | 81 | 2024 | 758406 | 0.290 |
Why?
|
Kinetics | 5 | 2021 | 6371 | 0.280 |
Why?
|
Phthalimides | 2 | 2024 | 34 | 0.270 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2019 | 345 | 0.260 |
Why?
|
Amino Acid Motifs | 2 | 2019 | 929 | 0.260 |
Why?
|
Multiple Myeloma | 5 | 2022 | 5129 | 0.250 |
Why?
|
Neoplasms | 6 | 2024 | 22032 | 0.240 |
Why?
|
Flavivirus | 1 | 2024 | 22 | 0.240 |
Why?
|
Leukemia | 2 | 2023 | 1519 | 0.230 |
Why?
|
Leukemia, Myeloid, Acute | 4 | 2024 | 3599 | 0.230 |
Why?
|
Piperidones | 1 | 2024 | 37 | 0.230 |
Why?
|
Methylation | 2 | 2024 | 1080 | 0.230 |
Why?
|
Viral Envelope Proteins | 2 | 2024 | 638 | 0.230 |
Why?
|
Biotinylation | 1 | 2024 | 184 | 0.220 |
Why?
|
Enzyme Activation | 3 | 2023 | 3593 | 0.220 |
Why?
|
RNA, Transfer | 2 | 2023 | 289 | 0.220 |
Why?
|
Cell Nucleus | 3 | 2023 | 2907 | 0.220 |
Why?
|
Dibenzazepines | 1 | 2022 | 26 | 0.220 |
Why?
|
Piperazines | 4 | 2021 | 2511 | 0.210 |
Why?
|
Cell Proliferation | 11 | 2024 | 10416 | 0.210 |
Why?
|
Directed Molecular Evolution | 1 | 2024 | 158 | 0.210 |
Why?
|
Nucleocapsid | 1 | 2023 | 63 | 0.210 |
Why?
|
RNA Processing, Post-Transcriptional | 2 | 2023 | 414 | 0.210 |
Why?
|
Cytokine Receptor Common beta Subunit | 1 | 2022 | 22 | 0.210 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2022 | 66 | 0.210 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2021 | 27 | 0.200 |
Why?
|
Animals | 22 | 2024 | 167768 | 0.200 |
Why?
|
Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2021 | 53 | 0.200 |
Why?
|
Cyclin-Dependent Kinase 9 | 2 | 2021 | 67 | 0.190 |
Why?
|
DNA Damage | 5 | 2019 | 2439 | 0.190 |
Why?
|
Carrier Proteins | 4 | 2023 | 4938 | 0.190 |
Why?
|
tRNA Methyltransferases | 1 | 2021 | 52 | 0.190 |
Why?
|
Immunoglobulin G | 3 | 2022 | 4540 | 0.190 |
Why?
|
Antiviral Agents | 3 | 2024 | 3056 | 0.190 |
Why?
|
Chimera | 1 | 2022 | 452 | 0.190 |
Why?
|
Methanol | 1 | 2021 | 91 | 0.190 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2021 | 104 | 0.190 |
Why?
|
Morpholines | 1 | 2024 | 580 | 0.180 |
Why?
|
Mutation | 8 | 2024 | 29915 | 0.180 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2021 | 213 | 0.180 |
Why?
|
Pyrrolidines | 1 | 2022 | 337 | 0.180 |
Why?
|
Molecular Conformation | 2 | 2019 | 543 | 0.180 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2021 | 223 | 0.180 |
Why?
|
Oncogenes | 2 | 2023 | 1220 | 0.180 |
Why?
|
Indoleacetic Acids | 1 | 2020 | 44 | 0.180 |
Why?
|
Eukaryotic Initiation Factor-4E | 1 | 2021 | 112 | 0.180 |
Why?
|
Virus Internalization | 1 | 2024 | 494 | 0.180 |
Why?
|
Pyridines | 3 | 2021 | 2859 | 0.180 |
Why?
|
Eukaryota | 1 | 2021 | 100 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 191 | 0.180 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2024 | 677 | 0.170 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2021 | 256 | 0.170 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2021 | 211 | 0.170 |
Why?
|
Oncogene Proteins | 2 | 2021 | 719 | 0.170 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2020 | 183 | 0.170 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2024 | 10748 | 0.170 |
Why?
|
RNA-Binding Protein EWS | 1 | 2021 | 210 | 0.170 |
Why?
|
Spodoptera | 1 | 2019 | 141 | 0.170 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2022 | 374 | 0.170 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2020 | 112 | 0.170 |
Why?
|
Jurkat Cells | 1 | 2021 | 735 | 0.170 |
Why?
|
Cross Reactions | 1 | 2021 | 818 | 0.170 |
Why?
|
HCT116 Cells | 2 | 2017 | 402 | 0.170 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2024 | 1245 | 0.160 |
Why?
|
Lower Extremity Deformities, Congenital | 1 | 2018 | 12 | 0.160 |
Why?
|
Inflammasomes | 1 | 2024 | 527 | 0.160 |
Why?
|
Databases, Protein | 1 | 2020 | 387 | 0.160 |
Why?
|
Upper Extremity Deformities, Congenital | 1 | 2018 | 32 | 0.150 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2019 | 555 | 0.150 |
Why?
|
GTP-Binding Proteins | 1 | 2023 | 950 | 0.150 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2021 | 509 | 0.150 |
Why?
|
Lysine | 1 | 2022 | 998 | 0.150 |
Why?
|
Teratogens | 1 | 2018 | 117 | 0.150 |
Why?
|
Immunologic Surveillance | 1 | 2018 | 92 | 0.150 |
Why?
|
Viral Nonstructural Proteins | 1 | 2019 | 223 | 0.150 |
Why?
|
Mice | 15 | 2024 | 81101 | 0.150 |
Why?
|
Phosphorylation | 7 | 2023 | 8297 | 0.150 |
Why?
|
Xenopus | 1 | 2019 | 717 | 0.150 |
Why?
|
Cullin Proteins | 3 | 2016 | 178 | 0.140 |
Why?
|
Species Specificity | 2 | 2018 | 2417 | 0.140 |
Why?
|
Immunity, Humoral | 1 | 2021 | 604 | 0.140 |
Why?
|
Mammals | 1 | 2022 | 1132 | 0.140 |
Why?
|
Pyrimidinones | 1 | 2019 | 383 | 0.140 |
Why?
|
Leukocytes, Mononuclear | 1 | 2024 | 1826 | 0.140 |
Why?
|
Purines | 1 | 2020 | 605 | 0.140 |
Why?
|
Lymphoma, B-Cell | 1 | 2023 | 935 | 0.140 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2023 | 1594 | 0.140 |
Why?
|
Isoenzymes | 1 | 2021 | 1686 | 0.140 |
Why?
|
Protein Structure, Secondary | 1 | 2019 | 1229 | 0.140 |
Why?
|
Tubulin | 1 | 2020 | 692 | 0.130 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2021 | 772 | 0.130 |
Why?
|
Nucleotidyltransferases | 1 | 2018 | 243 | 0.130 |
Why?
|
Biphenyl Compounds | 1 | 2021 | 988 | 0.130 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2018 | 237 | 0.130 |
Why?
|
Signal Transduction | 8 | 2023 | 23342 | 0.130 |
Why?
|
Frontotemporal Dementia | 1 | 2019 | 246 | 0.130 |
Why?
|
Protein Interaction Mapping | 1 | 2019 | 616 | 0.130 |
Why?
|
Protease Inhibitors | 1 | 2019 | 754 | 0.130 |
Why?
|
Acrylamides | 1 | 2017 | 259 | 0.130 |
Why?
|
Pyrazines | 1 | 2021 | 1198 | 0.130 |
Why?
|
Pyrimidines | 4 | 2021 | 3006 | 0.130 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2018 | 460 | 0.120 |
Why?
|
Tauopathies | 1 | 2019 | 317 | 0.120 |
Why?
|
Ubiquitins | 3 | 2023 | 366 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2024 | 2443 | 0.120 |
Why?
|
Autophagy | 1 | 2023 | 1322 | 0.120 |
Why?
|
Quinazolines | 2 | 2021 | 1360 | 0.120 |
Why?
|
Cell Survival | 3 | 2021 | 5781 | 0.120 |
Why?
|
Lysosomes | 1 | 2020 | 919 | 0.120 |
Why?
|
Principal Component Analysis | 1 | 2017 | 940 | 0.120 |
Why?
|
Drug Resistance, Viral | 1 | 2019 | 860 | 0.120 |
Why?
|
Proto-Oncogene Proteins | 2 | 2024 | 4485 | 0.110 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2017 | 495 | 0.110 |
Why?
|
Benzamides | 1 | 2019 | 1368 | 0.110 |
Why?
|
Stress, Physiological | 1 | 2021 | 1398 | 0.110 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2021 | 1245 | 0.110 |
Why?
|
GTP Phosphohydrolases | 1 | 2016 | 517 | 0.100 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2021 | 1067 | 0.100 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 2 | 2023 | 186 | 0.100 |
Why?
|
Neuroprotective Agents | 1 | 2019 | 955 | 0.100 |
Why?
|
Xeroderma Pigmentosum Group A Protein | 1 | 2011 | 13 | 0.100 |
Why?
|
Pyrazoles | 2 | 2019 | 1988 | 0.100 |
Why?
|
ras Proteins | 1 | 2017 | 1049 | 0.100 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2016 | 568 | 0.100 |
Why?
|
Hormones | 1 | 2016 | 869 | 0.100 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1725 | 0.100 |
Why?
|
Embryonic Stem Cells | 1 | 2018 | 1262 | 0.090 |
Why?
|
Abnormalities, Multiple | 1 | 2018 | 1414 | 0.090 |
Why?
|
RNA-Binding Proteins | 1 | 2019 | 1894 | 0.090 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2019 | 2416 | 0.090 |
Why?
|
Ultraviolet Rays | 2 | 2015 | 1076 | 0.090 |
Why?
|
Protein Stability | 2 | 2022 | 566 | 0.090 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2189 | 0.090 |
Why?
|
Enzyme Inhibitors | 1 | 2020 | 3709 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2022 | 3533 | 0.080 |
Why?
|
Gene Deletion | 1 | 2017 | 2666 | 0.080 |
Why?
|
Bone Neoplasms | 1 | 2021 | 2531 | 0.080 |
Why?
|
RNA, Messenger | 2 | 2021 | 12759 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4406 | 0.080 |
Why?
|
DNA Repair | 2 | 2023 | 2038 | 0.080 |
Why?
|
tau Proteins | 1 | 2019 | 2085 | 0.080 |
Why?
|
Lung Neoplasms | 3 | 2023 | 13245 | 0.070 |
Why?
|
Myelodysplastic Syndromes | 1 | 2017 | 1392 | 0.070 |
Why?
|
Allosteric Regulation | 2 | 2020 | 426 | 0.070 |
Why?
|
Mice, SCID | 2 | 2024 | 2626 | 0.070 |
Why?
|
Amino Acid Sequence | 1 | 2018 | 13447 | 0.070 |
Why?
|
Gene Expression Regulation | 1 | 2024 | 11892 | 0.070 |
Why?
|
Protein Structure, Tertiary | 3 | 2018 | 3796 | 0.060 |
Why?
|
Breast Neoplasms | 2 | 2024 | 21017 | 0.060 |
Why?
|
Pandemics | 2 | 2022 | 8611 | 0.060 |
Why?
|
Homeodomain Proteins | 1 | 2014 | 2413 | 0.060 |
Why?
|
Cells, Cultured | 1 | 2020 | 18940 | 0.060 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2018 | 1693 | 0.060 |
Why?
|
DNA | 1 | 2018 | 7199 | 0.060 |
Why?
|
Culicidae | 1 | 2024 | 108 | 0.060 |
Why?
|
Mitogens | 1 | 2024 | 230 | 0.060 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2024 | 3574 | 0.060 |
Why?
|
Co-Repressor Proteins | 1 | 2023 | 191 | 0.050 |
Why?
|
Azepines | 1 | 2024 | 329 | 0.050 |
Why?
|
Protein Conformation | 2 | 2022 | 3966 | 0.050 |
Why?
|
Allosteric Site | 1 | 2022 | 103 | 0.050 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2024 | 441 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2021 | 6127 | 0.050 |
Why?
|
Coronavirus OC43, Human | 1 | 2021 | 18 | 0.050 |
Why?
|
Interleukin-5 | 1 | 2022 | 269 | 0.050 |
Why?
|
Female | 9 | 2024 | 390323 | 0.050 |
Why?
|
Guanosine | 1 | 2021 | 48 | 0.050 |
Why?
|
Heart Defects, Congenital | 1 | 2018 | 4673 | 0.050 |
Why?
|
Genes, Overlapping | 1 | 2021 | 36 | 0.050 |
Why?
|
Interleukin-3 | 1 | 2022 | 425 | 0.050 |
Why?
|
Immunologic Tests | 1 | 2021 | 103 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2024 | 640 | 0.050 |
Why?
|
Trans-Activators | 2 | 2021 | 2860 | 0.050 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2024 | 685 | 0.050 |
Why?
|
Erythroid Cells | 1 | 2022 | 235 | 0.050 |
Why?
|
Phenotype | 1 | 2018 | 16534 | 0.040 |
Why?
|
Phenothiazines | 1 | 2020 | 61 | 0.040 |
Why?
|
Dipeptides | 1 | 2022 | 386 | 0.040 |
Why?
|
Hydrogen Bonding | 1 | 2020 | 290 | 0.040 |
Why?
|
Enzyme Activators | 1 | 2020 | 57 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20055 | 0.040 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 131 | 0.040 |
Why?
|
Young Adult | 3 | 2021 | 58808 | 0.040 |
Why?
|
Recombinant Proteins | 2 | 2021 | 6520 | 0.040 |
Why?
|
Benzylamines | 1 | 2021 | 247 | 0.040 |
Why?
|
Immunoglobulin Class Switching | 1 | 2021 | 289 | 0.040 |
Why?
|
Neurons | 1 | 2019 | 9416 | 0.040 |
Why?
|
Imides | 1 | 2019 | 15 | 0.040 |
Why?
|
Solvents | 1 | 2020 | 292 | 0.040 |
Why?
|
Models, Immunological | 1 | 2021 | 513 | 0.040 |
Why?
|
Adolescent | 3 | 2022 | 87892 | 0.040 |
Why?
|
Prodrugs | 1 | 2021 | 259 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 886 | 0.040 |
Why?
|
Triazoles | 1 | 2024 | 902 | 0.040 |
Why?
|
G1 Phase | 1 | 2020 | 403 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2023 | 855 | 0.040 |
Why?
|
Asymptomatic Diseases | 1 | 2021 | 584 | 0.040 |
Why?
|
Aminopyridines | 1 | 2022 | 564 | 0.040 |
Why?
|
Synthetic Biology | 1 | 2020 | 185 | 0.040 |
Why?
|
Serine | 1 | 2022 | 828 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 802 | 0.040 |
Why?
|
Cytoplasm | 1 | 2022 | 1514 | 0.040 |
Why?
|
Genome, Human | 1 | 2011 | 4416 | 0.040 |
Why?
|
Interleukin-1beta | 1 | 2024 | 996 | 0.040 |
Why?
|
Protein Transport | 1 | 2024 | 1963 | 0.040 |
Why?
|
Phenylurea Compounds | 1 | 2021 | 529 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2021 | 534 | 0.040 |
Why?
|
Benzofurans | 1 | 2018 | 140 | 0.040 |
Why?
|
Nucleotides, Cyclic | 1 | 2018 | 84 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2020 | 714 | 0.040 |
Why?
|
Gene Expression | 2 | 2022 | 7583 | 0.040 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2018 | 198 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2021 | 979 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2023 | 1752 | 0.040 |
Why?
|
Carrier State | 1 | 2021 | 525 | 0.040 |
Why?
|
Phthalazines | 1 | 2019 | 382 | 0.040 |
Why?
|
Cell Death | 1 | 2022 | 1668 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2017 | 462 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2020 | 655 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2022 | 1557 | 0.030 |
Why?
|
Protein Subunits | 1 | 2020 | 942 | 0.030 |
Why?
|
Apoproteins | 1 | 2016 | 45 | 0.030 |
Why?
|
Oxazoles | 1 | 2017 | 199 | 0.030 |
Why?
|
Protein Engineering | 1 | 2020 | 541 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2021 | 856 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2021 | 1133 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 621 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1613 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2022 | 1888 | 0.030 |
Why?
|
Sulfones | 1 | 2018 | 446 | 0.030 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2024 | 1547 | 0.030 |
Why?
|
Chemotaxis | 1 | 2018 | 598 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2022 | 1651 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 998 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1136 | 0.030 |
Why?
|
Amides | 1 | 2017 | 447 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2023 | 1972 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 1610 | 0.030 |
Why?
|
Molecular Dynamics Simulation | 1 | 2017 | 432 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1825 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2532 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3298 | 0.030 |
Why?
|
Oligopeptides | 1 | 2019 | 1185 | 0.030 |
Why?
|
Adenine | 1 | 2018 | 975 | 0.030 |
Why?
|
Cell Division | 1 | 2020 | 4458 | 0.030 |
Why?
|
Hepacivirus | 1 | 2019 | 1333 | 0.030 |
Why?
|
Vibrio cholerae | 1 | 2018 | 793 | 0.020 |
Why?
|
Male | 4 | 2024 | 358747 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2022 | 2980 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1931 | 0.020 |
Why?
|
Survivors | 1 | 2021 | 2370 | 0.020 |
Why?
|
Thiazoles | 1 | 2017 | 1510 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2017 | 1477 | 0.020 |
Why?
|
Piperidines | 1 | 2018 | 1639 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1740 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2022 | 3384 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2796 | 0.020 |
Why?
|
Middle Aged | 2 | 2021 | 219568 | 0.020 |
Why?
|
Risk | 1 | 2021 | 9599 | 0.020 |
Why?
|
Adult | 2 | 2021 | 219935 | 0.020 |
Why?
|
DNA Repair Enzymes | 1 | 2011 | 344 | 0.020 |
Why?
|
Hepatitis C | 1 | 2019 | 1579 | 0.020 |
Why?
|
Macrophages | 1 | 2024 | 5737 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 41256 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3561 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4641 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10171 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5790 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8506 | 0.010 |
Why?
|
Disease Progression | 1 | 2021 | 13468 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2023 | 18119 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4876 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15785 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10718 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12604 | 0.010 |
Why?
|
Models, Genetic | 1 | 2011 | 3441 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 26183 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5246 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36055 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42062 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54137 | 0.010 |
Why?
|
Child | 1 | 2021 | 79818 | 0.010 |
Why?
|
Aged | 1 | 2021 | 168218 | 0.000 |
Why?
|